<DOC>
	<DOCNO>NCT01631201</DOCNO>
	<brief_summary>This study test safety effectiveness investigational antibiotic drug , rifalazil treatment uncomplicated genital Chlamydia trachomatis infection . This study examine effect 25 milligram rifalazil compare azithromycin 1 gram , give single dose woman genital chlamydial infection .</brief_summary>
	<brief_title>Safety Efficacy Study Rifalazil Treatment Chlamydia Trachomatis Infection Women</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Chlamydia Infections</mesh_term>
	<mesh_term>KRM 1648</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>Female â‰¥ 19 year old diagnose genital chlamydia trachomatis infection . Use effective method contraception . Agree abstinent partner use condom sexual activity study . Subject sexual partner know gonorrhea . History repeat chlamydia trachomatis infection . HIV , syphilis , active Hepatitis B C infection . Treatment antimicrobial therapy know activity chlamydia trachomatis within 4 week enrollment .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Chlamydia</keyword>
</DOC>